The Spanish pharmaceutical laboratory Adventia Pharma continues to expand its range of innovation solutions for specialized clinical nutrition patients with the presentation of the Bi1 Via Diacare hp / hc and Bi1 Via Procare .

Adventia Pharma was the first laboratory to introduce extra virgin olive oil (EVOO) in enteral nutrition formulations. An innovation that aims to replace vegetable oils with a raw material of higher nutritional quality.

This year Adventia presents two new diets for patients who require tube nutrition. A type of generalized diet in the hospital setting, and intended for people whose digestive tract functions normally but who cannot eat enough to satisfy their nutritional needs, such as patients in a coma or a very reduced alert state, of liver failure or patients with serious diseases and mainly oncological.

For surgical and oncological patients, Bi1 Via Procare is the new diet from Adventia Pharma. This new diet for catheter is formulated with EVOO and is enriched in L-arginine, EPA and DHA.

In the case of diabetic patients, Bi1 Via Diacare hp / hc has It was developed taking into account the beneficial action provided by lipids and phenolic compounds in EVOO.

Both diets will be presented by Adventia Pharma during the National Congress of the Spanish Society of Clinical Nutrition and Metabolism which is celebrated between September 10 and 12.

Virgin Olive Oil of national origin

Last January Adventia Pharma and Picualia communicated the agreement according to which the Jienense cooperative is since this year the laboratory's supplier of extra virgin olive oil for all its clinical nutrition diets.